Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold
Abdelfattah Hassan, Mohamed Badr, Dalia Abdelhamid, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105631-105631
Closed Access | Times Cited: 15

Showing 15 citing articles:

Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors
Moataz A. Shaldam, Hadia Almahli, Andrea Angeli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 26
Design, Synthesis, and In Silico Insights of new 4‐Piperazinylquinolines as Antiproliferative Agents against NCI Renal Cancer Cell Lines
Gabriele La Monica, Alessia Bono, Federica Alamia, et al.
ChemistryOpen (2025)
Open Access
Design and biological evaluation of 3-substituted quinazoline-2,4(1 H ,3 H )-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors
Abdelfattah Hassan, Fawzy A. F. Mubarak, Ihsan A. Shehadi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 19
Novel 3-phenylquinazolin-2,4(1H,3H)-diones as dual VEGFR-2/c-Met-TK inhibitors: design, synthesis, and biological evaluation
Abdelfattah Hassan, Ahmed Mohamed Mosallam, Amal O. A. Ibrahim, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities
Hamada Hashem, Abdelfattah Hassan, Walid M. Abdelmagid, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1154-1154
Open Access | Times Cited: 4
Recent Advances and Future Directions on Small Molecule VEGFR Inhibitors in Oncological Conditions
Amandeep Thakur, Mandeep Rana, Anshul Mishra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116472-116472
Closed Access | Times Cited: 3
Design, synthesis, molecular dynamics simulation, MM/GBSA studies and kinesin spindle protein inhibitory evaluation of some 4-aminoquinoline hybrids
Shriram D. Ranade, Shankar G. Alegaon, Venkatasubramanian Ulaganathan, et al.
Computational Biology and Chemistry (2023) Vol. 105, pp. 107881-107881
Closed Access | Times Cited: 10
Redefining the significance of quinoline containing compounds as potent VEGFR-2 inhibitors for cancer therapy
Jurnal Reang, Vinita Sharma, Vivek Yadav, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 7, pp. 1079-1099
Closed Access | Times Cited: 1
Metabolite profiling of green algae Halimeda opuntia to target hepatitis C virus-796 polymerase inhibitors assisted by molecular docking
Iman A. M. Abdel-Rahman, Eman Zekry Attia, Omar M. Aly, et al.
South African Journal of Botany (2022) Vol. 151, pp. 538-543
Closed Access | Times Cited: 8
Novel azole-urea hybrids as VEGFR-2 inhibitors: Synthesis, in vitro antiproliferative evaluation and in silico studies
Mohammad Musa Shirzad, Necla Kulabaş, Ömer Erdoğan, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136448-136448
Closed Access | Times Cited: 4
Affinity character analysis of magnolol and honokiol based on stepwise frontal analysis coupled with cell membrane chromatography
Xiaoshuang He, M. Zhang, Fen Wei, et al.
Journal of Chromatography B (2023) Vol. 1229, pp. 123903-123903
Closed Access | Times Cited: 2
Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability
Tengfei Chen, Jun Chen, Qiuyun Chen, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 2, pp. 1424-1437
Open Access
Apatinib reduces liver cancer cell multidrug resistance by modulating NF-κB signaling pathway
XIAOXIAO HE, XUEQING ZHOU, J. Zhang, et al.
Biocell (2024) Vol. 48, Iss. 9, pp. 1331-1341
Open Access
Fucoxanthin Attenuates Angiogenesis by Blocking the VEGFR2-Mediated Signaling Pathway through Binding the Vascular Endothelial Growth Factor
Guo-Xia Guo, Yu-Huan Qiu, Yang Liu, et al.
Journal of Agricultural and Food Chemistry (2024)
Closed Access
Identification of potentially high drug-like VEGFR2/c-Met dual-target type II kinase inhibitors with symmetric skeletons based on structural screening
Jiali Xie, Xiaoxuan Zhang, Dan Meng, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 3, pp. 1249-1267
Closed Access | Times Cited: 1
EGFR, and VEGFR inhibitory activities of the crude extract from marine algae Dictyopteris acrostichoides supported by in silico analysis and metabolic profiling
Eman Zekry Attia, Iman A. M. Abdel-Rahman, Omar M. Aly, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top